Haemonetics Corporation
$108.40
$0.80 (+0.74%)
$107.60Day Range$110.45
Key Statistics
Market Cap
$4.93B
Shares Outstanding
45.5M
Primary Exchange
XNYS
Currency
USD
Type
CS
IPO Date
May 9, 1991
Round Lot
100
Locale
US
Trading Data
Day Open
$108.95
Day High
$110.45
Day Low
$107.60
Volume
1.30M
VWAP
$108.69
Prev Close
$107.60
Transactions
--
Acc. Volume
--
About Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 38413,009 employees125 SUMMER STREET, BOSTON, MA, 02110(781) 848-7100IPO May 9, 1991US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000313143
- Composite FIGI
- BBG000C7TF41
- Share Class FIGI
- BBG001S6QB64
- Ticker Root
- HAE
- SIC Code
- 3841
About Haemonetics Corporation (HAE) Stock
Haemonetics Corporation (HAE) closed the 2026-09-18 session at $108.40, up 0.74% versus the previous close (+0.80). The stock opened at $108.95 and traded between $107.60 and $110.45 during that session. Session trading volume was 1.3M shares. The volume-weighted average price (VWAP) is $108.69.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Haemonetics Corporation has a market capitalization of $4.93 billion. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. HAE is listed on the XNYS exchange. The company employs approximately 3,009 people. Haemonetics Corporation is headquartered in BOSTON, MA. The recorded listing date is 1991-05-09.
On this page you can find market HAE stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.